Covid Vaccine Makers May Need to Infect Subjects to Get Results
If the disease ebbs further in some regions, not enough people will be exposed to the coronavirus to make studies
Read moreIf the disease ebbs further in some regions, not enough people will be exposed to the coronavirus to make studies
Read moreHome teams have won only 14 per cent of games played behind closed doors in Germany Last Updated: 27/05/20 9:50am
Read moreNovavax (NVAX) is now beginning human testing in its Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373. Preliminary
Read moreVANCOUVER, May 26, 2020 /CNW/ – TAAL Distributed Information Technologies Inc. (CSE:TAAL | FWB:9SQ) (“TAAL” or the “Company“) today announced
Read moreEnglish football was halted in mid-March due to the COVID-19 pandemic but clubs are training in small groups as part
Read moreThe Covid-19 treatment triggered an immune system response in more than 100 participants in the phase one trial; Volunteers did
Read morePRINCETON, N.J., May 18, 2020 /PRNewswire/ — Plummeting revenues and rising expenses during New Jersey’s COVID-19 crisis have had a severe
Read moreUEFA president Aleksander Ceferin believes that French football’s 2019/20 season was prematurely brought to an end and he doesn’t think
Read moreThe House is voting on Friday on the $3 trillion stimulus package for coronavirus relief that the Democrats introduced on
Read moreWALL, N.J., May 15, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric software and
Read more